News

MUP successfully launched the first Egyptian human insulin vial with American Standard and international technology produced from (MUP- TECH) Factory and with the brand name Insulinagypt.

MUP recently acquired human insulin (Vial) factory of American company Eli Lilly and Company in the sixth of October, which is one of the five factories for the production of human insulin owned by Eli Lilly worldwide and changed the name of the factory to (MUP- TECH).

According to the Memorandum of the Understanding signed on November 4, 2014 Between MUP & Eli- Lilly under the patronage of the Minister of Health and population of Egypt. On December 21, 2014 MUP & Eli-Lilly –USA signed three agreements: First agreement "Factory Purchase agreement" concerning MUP acquiring of Eli-Lilly factory which produce human Insulin vials, located in 6th October City , Egypt. Production planed to be in the Egyptian market within weeks.

Companies sign memorandum of understanding for acquisition of human insulin vials manufacturing plant in Cairo, Egypt under the patronage of the Ministry of Health and population of Egypt

Egypt (Nov 5, 2014)- Eli Lilly and company and Medical Union Pharmaceuticals (MUP), a subsidiary of ACDIMA, announced today that the companies have signed a non-binding memorandum of understanding for MUP’s acquisition of Lilly’s human insulin vials manufacturing plant located in the 6th of October city , Egypt. The deal is expected to be finalized during 2015.